Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-6

The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma

Julia Maués, Anne Loeser, Janice Cowden [...]

Clinical Trials

Retricted access

Research article

First published 2024-6

Optimizing the doses of cancer drugs after usual dose finding

Garth W Strohbehn, Walter M Stadler, Philip S Boonstra [...]

Clinical Trials

Open access

Review article

First published 2019-12-24

Individualization of Dose and Schedule Based On Toxicity for Oral VEGF Drugs in Kidney Cancer

Ambika Parmar, Georg A. Bjarnason

Kidney Cancer

Retricted access

Research article

First published 2010-6

Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin

Sarah Jennings, Mário L de Lemos, Adeera Levin [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2014-9

Negative-balance isolated pelvic perfusion in patients with incurable symptomatic rectal cancer: results and drug dose correlation to adverse events

Satoru Murata, Shiro Onozawa, Chol Kim [...]

Acta Radiologica

Retricted access

Research article

First published 2024-6

Applications of the partial-order continual reassessment method in the early development of treatment combinations

Nolan A Wages, Patrick M Dillon, Craig A Portell [...]

Clinical Trials

Open access

Research article

First published 2019-10

Quantitative Evaluation of Hormesis in Breast Cancer Using Histoculture Drug Response Assay

Yuka Aoishi

Dose-Response

Retricted access

Research article

First published 2025

Dose standardisation of intravenous anticancer drugs: Risk analysis and implementation in a French cancer centre

Khevin Itoua-Gassaye, Mallory Friou, Laurence Escalup [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis

Alessandro Rizzo, Margherita Nannini, Marco Novelli [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2018-8

Human Papilloma Virus-Type 16 (HPV-16) & Human Herpes Virus-Type 8 (HHV-8) infections were found to be co-existing major cancer-contributing factors. Individualized,safe,effective treatment of hopelessly advanced cancer patients with metastasis by combining 4 methods of effective treatment: 1) Optimal dose of Vitamin D3 using its 10 unique beneficial effects,2) Selective Drug Uptake Enhancement Method,3) Stimulation of newly discovered Thymus gland representation areas on the back of each hand,& 4) Identification & removal of co-existing cancer-contributing factors

Yoshiaki Omura, Dominic Lu, Harsha Duvvi [...]

Acupuncture & Electro-Therapeutics Research: International Journal of Integrated Medicine

Search results